Global Proton Therapy Market, By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes) – Industry Trends and Forecast to 2031.
Proton Therapy Market Analysis and Size
The presence of cancer-causing viruses and faulty genes adds to the burden of cancer among people. Thus, the increased prevalence of cancer acts as a driver for the growth of the market. The high cost of proton therapy leading to high-cost treatment acts as a restraint for the growth of the proton therapy market. The increased awareness is reflected in the surging research and development in the area leading to the increased amount of clinical data coming up showcasing the benefits of treatment. Thus, the growing recognition of proton therapy acts as an opportunity for the growth of the market. The expensive treatment as compared to other technologies acts as a restraint for its growth in the market.
Data Bridge Market Research analyzes that the global proton therapy market which was USD 1693.13 million in 2023, is expected to reach USD 2,791.61 million by 2031, and is expected to undergo a CAGR of 6.45% during the forecast period of 2024 to 2031. “Systems” dominates the product segment of the market due to rising demand for proton therapy. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Product Type (Systems, Software, Services), Component (Proton Accelerator, Beam Transport System, Beam Delivery System, Nozzle, Image Viewers, Patient Positioning System (PPS)), Type (Rotating Proton Therapy Systems, Non Rotating Proton Therapy Systems), Set-Up Systems (Multi-Room Systems, Compact/ Single-Room Systems), Application Type (Treatment Applications, Research Applications), End User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes)
|
|
Countries Covered
|
U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Rest of Middle East and Africa, Brazil, Rest of South America
|
|
Market Players Covered
|
ProTom International, Varian Medical Systems, Inc., (Siemens Healthineers), Mevion Medical Systems, Hitachi, Ltd., Sumitomo Heavy Industries, Ltd., Optivus Proton Therapy Inc., IBA Worldwide, Provision Healthcare, Toshiba Corporation, ITEL Telecomunicazioni S.r.l.
|
|
Market Opportunities
|
|
Market Definition
The proton therapy is the most precise and accurate radiation therapy which utilizes the energy of proton particles for killing the cancerous cells or the desired cell at a particular location. The major limitations of photon therapy or other particle therapy are overcome by proton therapy. The advancement in technology has increased the adoption of proton therapy for the treatment of various cancers across the globe.
Global Proton Therapy Market Dynamics
Drivers
- Rising Incidence of Pediatric Cancers
The escalating prevalence of pediatric cancers, coupled with the sensitivity of children to radiation, has amplified the use of proton therapy in pediatric oncology. Proton therapy's ability to precisely target tumors while minimizing radiation exposure to healthy tissues aligns with the stringent requirements of pediatric cancer treatment, fostering its increased utilization. The rising incidence of pediatric cancers has been a significant driver behind the growing adoption of proton therapy.
- Increasing Awareness and Patient Preference
Growing awareness among patients and healthcare professionals about the advantages of proton therapy, such as reduced side effects and enhanced treatment efficacy, has contributed to its rising adoption. Patients, especially those with pediatric cancers or tumors located near critical organs, prefer proton therapy due to its precision and reduced risk of long-term complications. The increasing knowledge and preference among patients and healthcare providers are key drivers fueling the demand for proton therapy globally.
- Technological Advancements in Proton Therapy
Ongoing technological innovations in proton therapy have significantly enhanced its precision and efficiency. Advanced techniques such as pencil beam scanning (PBS) and intensity-modulated proton therapy (IMPT) enable more accurate tumor targeting and better sparing of surrounding healthy tissues. These innovations have broadened the applicability of proton therapy across various cancer types and stages. The continuous enhancement and sophistication of proton therapy technologies act as a compelling driver, attracting healthcare providers and patients alike towards its benefits.
Opportunities
- Government Support and Investments
Supportive government initiatives, funding, and collaborations have facilitated the establishment of proton therapy centers. Favorable reimbursement policies and financial incentives have encouraged healthcare institutions to invest in proton therapy facilities, making the treatment more accessible and affordable for patients. The significant role played by governmental support and funding initiatives has propelled the growth of the proton therapy market, particularly in regions where healthcare infrastructure is expanding.
- Collaborations and Strategic Alliances
Collaborations and strategic alliances between equipment manufacturers, healthcare institutions, research organizations, and regulatory body’s present opportunities for innovation and market expansion. Partnerships can facilitate knowledge exchange, technology transfer, and access to new markets. Joint ventures between manufacturers and healthcare providers can focus on developing tailored solutions, sharing expertise, and conducting clinical trials. This collaboration can lead to the development of more efficient and reliable bypass accessory equipment, ensuring safer procedures and better patient outcomes.
Restraints/Challenges
- High Initial Setup and Operational Costs
The construction and operation of proton therapy centers involve substantial capital investment and ongoing operational expenses. The high costs associated with building, equipping, and maintaining these specialized facilities create a financial barrier. Such expenses limit the establishment of new centers and may hinder patient access due to the concentration of facilities in certain regions.
-
Limited Accessibility and Geographic Constraints
Despite the increasing demand, the availability of proton therapy centers is limited, mainly concentrated in developed regions. This concentration creates geographical barriers, forcing patients from distant areas to travel long distances to access treatment. The lack of proximity and availability hampers timely and convenient access to proton therapy for many patients.
This proton therapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the proton therapy market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2022, Sun Nuclear Corporation, a subsidiary of Mirion Technologies unveiled SunSCAN 3D cylindrical water scanning system for beam scanning, linear accelerator commissioning, and annual Quality Assurance in Radiation Therapy. The new SunSCAN 3D water scanning system is an advanced addition to Sun Nuclear’s complete solutions offering for independent, combined Quality Management of Diagnostic Imaging and Radiation Therapy
Global Proton Therapy Market Scope
The proton therapy market is segmented on the basis of product type, component, type, set-up systems, application type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Systems
- Software
- Services
Components
- Proton Accelerator
- Beam Transport System
- Beam Delivery System
- Nozzle
- Image Viewers
- Patient Positioning System (PPS)
Type
- Rotating Proton Therapy Systems
- Non Rotating Proton Therapy Systems
Set-up Systems
- Multi-Room Systems
- Compact/ Single-Room Systems
Application
- Treatment Applications
- Research Applications
End Users
- Hospitals
- Ambulatory Surgical Centers
- Cancer Research Institutes
Global Proton Therapy Market Regional Analysis/Insights
The proton therapy market is analysed and market size insights and trends are provided by country, product type, component, type, set-up systems, application type and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and rest of Middle East and Africa.
North America is expected to dominate the market in terms of market share and market revenue and will continue to flourish its dominance due of the increase in the expenditure for research. Also, the increasing government’s initiatives and improved health care infrastructure in various countries is also driving the regional growth.
Asia-Pacific is expected to exhibit the highest growth rate in the global proton therapy market during the forecast period of 2024 to 2031 due to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Proton Therapy Market Share Analysis
The proton therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to proton therapy market.
Some of the major players operating in the proton therapy market are:
- ProTom International
- Varian Medical Systems, Inc., (Siemens Healthineers)
- Mevion Medical Systems
- Hitachi, Ltd.,
- Sumitomo Heavy Industries, Ltd.,
- Optivus Proton Therapy Inc.,
- IBA Worldwide
- Provision Healthcare
- Toshiba Corporation
- ITEL Telecomunicazioni S.r.l.
SKU-